CompletedPhase 2NCT04855305

Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

Studying Interstitial lung disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bastiaan Driehuys
Principal Investigator
Joseph Mammarappallil, MD
Duke University
Intervention
Hyperpolarized 129Xe(drug)
Enrollment
46 target
Eligibility
18 years · All sexes
Timeline
20212025

Study locations (4)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · Children's Hospital Medical Center, Cincinnati · University of Cincinnati · University of Iowa

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04855305 on ClinicalTrials.gov

Other trials for Interstitial lung disease

Additional recruiting or active studies for the same condition.

See all trials for Interstitial lung disease

← Back to all trials